BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 32981055)

  • 1. A glance over the fence: Using phylogeny and species comparison for a better understanding of antigen recognition by human γδ T-cells.
    Herrmann T; Karunakaran MM; Fichtner AS
    Immunol Rev; 2020 Nov; 298(1):218-236. PubMed ID: 32981055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heteromeric interactions regulate butyrophilin (BTN) and BTN-like molecules governing γδ T cell biology.
    Vantourout P; Laing A; Woodward MJ; Zlatareva I; Apolonia L; Jones AW; Snijders AP; Malim MH; Hayday AC
    Proc Natl Acad Sci U S A; 2018 Jan; 115(5):1039-1044. PubMed ID: 29339503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the Vγ9Vδ2 TCR and Is Essential for Phosphoantigen Sensing.
    Karunakaran MM; Willcox CR; Salim M; Paletta D; Fichtner AS; Noll A; Starick L; Nöhren A; Begley CR; Berwick KA; Chaleil RAG; Pitard V; Déchanet-Merville J; Bates PA; Kimmel B; Knowles TJ; Kunzmann V; Walter L; Jeeves M; Mohammed F; Willcox BE; Herrmann T
    Immunity; 2020 Mar; 52(3):487-498.e6. PubMed ID: 32155411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand recognition by the γδ TCR and discrimination between homeostasis and stress conditions.
    Deseke M; Prinz I
    Cell Mol Immunol; 2020 Sep; 17(9):914-924. PubMed ID: 32709926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butyrophilin3A proteins and Vγ9Vδ2 T cell activation.
    Gu S; Borowska MT; Boughter CT; Adams EJ
    Semin Cell Dev Biol; 2018 Dec; 84():65-74. PubMed ID: 29471037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unsynchronized butyrophilin molecules dictate cancer cell evasion of Vγ9Vδ2 T-cell killing.
    Wu Z; Lamao Q; Gu M; Jin X; Liu Y; Tian F; Yu Y; Yuan P; Gao S; Fulford TS; Uldrich AP; Wong CC; Wei W
    Cell Mol Immunol; 2024 Apr; 21(4):362-373. PubMed ID: 38374404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical sideways recognition of CD1a by autoreactive γδ T cell receptors.
    Wegrecki M; Ocampo TA; Gunasinghe SD; von Borstel A; Tin SY; Reijneveld JF; Cao TP; Gully BS; Le Nours J; Moody DB; Van Rhijn I; Rossjohn J
    Nat Commun; 2022 Jul; 13(1):3872. PubMed ID: 35790773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. γδ T cell antigen receptor polyspecificity enables T cell responses to a broad range of immune challenges.
    Guo J; Chowdhury RR; Mallajosyula V; Xie J; Dubey M; Liu Y; Li J; Wei YL; Palanski BA; Wang C; Qiu L; Ohanyan M; Kask O; Sola E; Kamalyan L; Lewis DB; Scriba TJ; Davis MM; Dodd D; Zeng X; Chien YH
    Proc Natl Acad Sci U S A; 2024 Jan; 121(4):e2315592121. PubMed ID: 38227652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR screens decode cancer cell pathways that trigger γδ T cell detection.
    Mamedov MR; Vedova S; Freimer JW; Sahu AD; Ramesh A; Arce MM; Meringa AD; Ota M; Chen PA; Hanspers K; Nguyen VQ; Takeshima KA; Rios AC; Pritchard JK; Kuball J; Sebestyen Z; Adams EJ; Marson A
    Nature; 2023 Sep; 621(7977):188-195. PubMed ID: 37648854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel insights into regulation of butyrophilin molecules: critical components of cancer immunosurveillance by γδ T cells.
    Kabelitz D
    Cell Mol Immunol; 2024 Apr; 21(4):409-411. PubMed ID: 38532044
    [No Abstract]   [Full Text] [Related]  

  • 11. Conserved γδ T cell selection by BTNL proteins limits progression of human inflammatory bowel disease.
    Dart RJ; Zlatareva I; Vantourout P; Theodoridis E; Amar A; Kannambath S; East P; Recaldin T; Mansfield JC; Lamb CA; Parkes M; Irving PM; Prescott NJ; Hayday AC
    Science; 2023 Sep; 381(6663):eadh0301. PubMed ID: 37708268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normality sensing licenses local T cells for innate-like tissue surveillance.
    McKenzie DR; Hart R; Bah N; Ushakov DS; Muñoz-Ruiz M; Feederle R; Hayday AC
    Nat Immunol; 2022 Mar; 23(3):411-422. PubMed ID: 35165446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering a Dual Specificity γδ T-Cell Receptor for Cancer Immunotherapy.
    Davies DM; Pugliese G; Parente Pereira AC; Whilding LM; Larcombe-Young D; Maher J
    Biology (Basel); 2024 Mar; 13(3):. PubMed ID: 38534465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune recognition of phosphoantigen-butyrophilin molecular complexes by γδ T cells.
    Uldrich AP; Rigau M; Godfrey DI
    Immunol Rev; 2020 Nov; 298(1):74-83. PubMed ID: 33017054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Effects of γδ T Cells in Colorectal Cancer: A Review.
    Ma R; Yuan D; Guo Y; Yan R; Li K
    Front Immunol; 2020; 11():1600. PubMed ID: 33013819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The distinct MHC-unrestricted immunobiology of innate-like and adaptive-like human γδ T cell subsets-Nature's CAR-T cells.
    Willcox CR; Mohammed F; Willcox BE
    Immunol Rev; 2020 Nov; 298(1):25-46. PubMed ID: 33084045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-33 activates regulatory T cells to suppress innate γδ T cell responses in the lung.
    Faustino LD; Griffith JW; Rahimi RA; Nepal K; Hamilos DL; Cho JL; Medoff BD; Moon JJ; Vignali DAA; Luster AD
    Nat Immunol; 2020 Nov; 21(11):1371-1383. PubMed ID: 32989331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphere-derived Prostate Cancer Stem Cells Are Resistant to γδ T Cell Cytotoxicity.
    Miyashita M; Tomogane M; Nakamura Y; Shimizu T; Fujihara A; Ukimura O; Ashihara E
    Anticancer Res; 2020 Oct; 40(10):5481-5487. PubMed ID: 32988870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic cancer patients.
    Lin M; Zhang X; Liang S; Luo H; Alnaggar M; Liu A; Yin Z; Chen J; Niu L; Jiang Y
    Signal Transduct Target Ther; 2020 Oct; 5(1):215. PubMed ID: 33093457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased Frequency of Intestinal CD39
    Libera J; Wittner M; Kantowski M; Woost R; Eberhard JM; de Heer J; Reher D; Huber S; Haag F; Schulze Zur Wiesch J
    Front Immunol; 2020; 11():567472. PubMed ID: 33072107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.